Fairvalue-Calculator Fairvalue-Calculator
EN DE

Bioventix PLC (BVXP) Fair Value & Analysis

Healthcare · GB · Market cap 86.7M GBX

Pricep18.00
Fair Valuep24.84
Upside+38.0%
Quality95/100
Evidence: High Range p15.60 – p34.45

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Bioventix PLC (BVXP) currently trades at p18.00, while our model-based Fair Value estimate is p24.84 — implying the stock looks roughly 38.0% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -84% Regeneron Pharmaceuticals, Inc (REGN) +109% UCB SA (UCB) -23% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +9% Alnylam Pharmaceuticals, Inc (ALNY) -64%

Frequently asked questions

Is Bioventix PLC (BVXP) undervalued?
As of Jun 24, 2026, our model estimates a fair value of p24.84 versus a price of p18.00 — about +38% (undervalued). Model-based estimate, not financial advice.
What is the fair value of BVXP?
Our 21-model fair value for Bioventix PLC is p24.84 (as of Jun 24, 2026), built from audited fundamentals. The current price is p18.00.
What is the quality score of BVXP?
Bioventix PLC has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.